Managing Director
and access,
Mr. Lee has more than 10 years of experience in managing equity funds and investing in unlisted stocks. As an investment manager at Medivate Partners, he is responsible for assessing corporate values based on macroeconomic analysis, deep understanding of biotech industries, and analysis of corporate financial statements. Prior to joining Medivate Partners, Mr. Lee managed Wrap accounts, IPO fund and equity funds in NH Investment & Securities, Square Investment Management, HI Asset Management, and Taurus Investment Management. Mr. Lee also worked at Samil PwC as a KICPA. Mr. Lee received his bachelor’s degree in Business Administration from Korea University in Seoul, Korea.
